Incyte Reports 2020 Fourth Quarter and Year-End Financial Results, Provides 2021 Financial Guidance and Updates on Key Clinical Programs

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. GOOGL
6. APGE
7. HOOD
8. DFTX
9. MU
10. IBM

Go back to Incyte Reports 2020 Fourth Quarter and Year-End Financial Results, Provides 2021 Financial Guidance and Updates on Key Clinical Programs

Incyte (INCY) Tops Q4 EPS by 18c, Revenues Beat

February 9, 2021 7:14 AM EST

Incyte (NASDAQ: INCY) reported Q4 EPS of $0.93, $0.18 better than the analyst estimate of $0.75. Revenue for the quarter came in at $789.51 million versus the consensus estimate of $662.94 million.

Our team achieved many important accomplishments in the past year. Revenue growth was strong, driven by demand... More